A clinical trial involving ganirelix has been registered as of May 7, 2026. The trial, titled "Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?", is listed under identifier NCT06877429.
According to the registration, the study status is not yet recruiting. No phase has been specified for this trial in the available record.
The trial appears designed to investigate whether diurnal cortisol variation seen in circulating levels is also reflected in follicular fluid from preovulatory follicles close to ovulation. No results have been posted, and no outcomes or findings are available at this time.
This entry reflects only the trial registration details as listed. Further updates, including recruitment status changes or eventual results, would be expected to appear on the official registration page as the study progresses.
Readers seeking more background on ganirelix, including its approved regulatory status and general use, can consult the compound overview for additional context.